Underweight and obesity as outcome predictors after transcatheter aortic valve implantation: insights from the DOUBLE-CHOICE trial

Abstract Background An “obesity paradox” has been described after transcatheter aortic valve implantation (TAVI), suggesting lower mortality in patients with higher body mass index (BMI) despite greater comorbidity. In contrast, underweight consistently predicts adverse outcomes. Whether these associations reflect a true biological effect or are primarily driven by residual confounding, frailty, and patient selection remains uncertain. Methods This prespecified subgroup analysis included eligible patients from the randomized DOUBLE-CHOICE trial comparing two transcatheter heart valves and two anesthesia strategies (minimalist approach with local anesthesia only vs. standard care with conscious sedation). The primary endpoint was a 30-day composite of all-cause mortality, vascular and bleeding complications, infections requiring antibiotic therapy, and neurologic events. Associations were evaluated using multivariable logistic regression adjusted for age, sex, frailty, diabetes, hypertension, chronic kidney disease, and anesthesia strategy. Results Among 752 patients (BMI ≥ 30 kg/m 2 , n = 192; BMI < 30 kg/m 2 , n = 560), obese patients had lower rates of the 30-day primary endpoint (15.2% vs. 27.6%; p < 0.001). After multivariable adjustment, obesity remained independently associated with lower risk (adjusted OR 0.48, 95% CI 0.30–0.75; p = 0.002). In contrast, underweight (BMI < 20 kg/m 2 ; n = 23) was associated with a higher incidence of the primary endpoint (55.0% vs. 23.4%; p = 0.003) and remained an independent predictor after adjustment (adjusted OR 3.74, 95% CI 1.30–9.52; p = 0.005). Conclusion In this randomized TAVI population, obesity was independently associated with favorable 30-day outcomes, whereas underweight identified a small but high-risk subgroup with substantially increased procedural risk. These findings identify underweight as a potential high-risk phenotype requiring further investigation in future studies incorporating more detailed measures of frailty and body composition.

Authors

Institutions

Publication Details

Journal
Clinical Research in Cardiology
Published
2026-11-12
DOI
https://doi.org/10.1007/s00392-026-03042-x
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Underweight and obesity as outcome predictors after transcatheter aortic valve implantation: insights from the DOUBLE-CHOICE trial

Steffen Maßberg, Michael Andrew Borger, Sven Hohenstein, Helge Möllmann et al.
Clinical Research in Cardiology
Cardiac Valve Diseases and Treatments
article

Underweight and obesity as outcome predictors after transcatheter aortic valve implantation: insights from the DOUBLE-CHOICE trial

Steffen Maßberg, Michael Andrew Borger, Sven Hohenstein, Helge Möllmann, Alexander Wolf, Mohamed Abdel‐Wahab, Andreas Boening, Stephan Ernst Baldus, Sabine Bleiziffer, Philipp Lauten, Michael Joner, Matti Adam, Tanja K. Rudolph, Steffen Desch, Tobias Geisler, Sebastian von der Emde, Niklas Lankisch, Maria Buske, Holger Thiele, Helene Schrader, Samuel Sossalla, Thilo Noack, Joerg Ender, Won-Keun Kim
article en

Abstract

Abstract Background An “obesity paradox” has been described after transcatheter aortic valve implantation (TAVI), suggesting lower mortality in patients with higher body mass index (BMI) despite greater comorbidity. In contrast, underweight consistently predicts adverse outcomes. Whether these associations reflect a true biological effect or are primarily driven by residual confounding, frailty, and patient selection remains uncertain. Methods This prespecified subgroup analysis included eligible patients from the randomized DOUBLE-CHOICE trial comparing two transcatheter heart valves and two anesthesia strategies (minimalist approach with local anesthesia only vs. standard care with conscious sedation). The primary endpoint was a 30-day composite of all-cause mortality, vascular and bleeding complications, infections requiring antibiotic therapy, and neurologic events. Associations were evaluated using multivariable logistic regression adjusted for age, sex, frailty, diabetes, hypertension, chronic kidney disease, and anesthesia strategy. Results Among 752 patients (BMI ≥ 30 kg/m 2 , n = 192; BMI < 30 kg/m 2 , n = 560), obese patients had lower rates of the 30-day primary endpoint (15.2% vs. 27.6%; p < 0.001). After multivariable adjustment, obesity remained independently associated with lower risk (adjusted OR 0.48, 95% CI 0.30–0.75; p = 0.002). In contrast, underweight (BMI < 20 kg/m 2 ; n = 23) was associated with a higher incidence of the primary endpoint (55.0% vs. 23.4%; p = 0.003) and remained an independent predictor after adjustment (adjusted OR 3.74, 95% CI 1.30–9.52; p = 0.005). Conclusion In this randomized TAVI population, obesity was independently associated with favorable 30-day outcomes, whereas underweight identified a small but high-risk subgroup with substantially increased procedural risk. These findings identify underweight as a potential high-risk phenotype requiring further investigation in future studies incorporating more detailed measures of frailty and body composition.

Clinical Research in Cardiology
Witten/Herdecke University (DE), University of Cologne (DE), Universitätsklinikum Gießen und Marburg (DE), Heart and Diabetes Center North Rhine-Westphalia (DE), Universitätsklinikum Tübingen (DE), Zentralklinik Bad Berka (DE), Leipzig Heart Institute (DE), Helios Park-Klinikum Leipzig (DE), University Hospital Leipzig (DE), St.-Johannes-Hospital Dortmund (DE), Deutsches Herzzentrum München (DE), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE), Leipzig University (DE)
Deutsche Stiftung für Herzforschung, Universität Leipzig, Dr. Rolf M. Schwiete Stiftung
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon